Recent Finacing
Recent Raise
Sphere Fluidics develops and commercializes the Cyto‑Mine picodroplet microfluidics platform, integrating single‑cell screening, sorting, dispensing, imaging and clone verification for antibody discovery and cell‑line development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
